𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Endobronchial administration of iodine-131 B72.3 monoclonal antibody in patients with lung cancer

✍ Scribed by Silvana Vecchio; Luigi Mansi; Antonella Petrillo; Luigi Camera; Matteo Sofia; Alberto Marra; Luigi Carratú; Marco Salvatore


Publisher
Springer
Year
1991
Tongue
English
Weight
693 KB
Volume
18
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Evaluation of therapeutic response using
✍ L. Camera; S. Vecchio; A. Petrillo; G. Esposito; G. Frasci; R. V. Iaffaioli; A. 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 755 KB

We used radiolabelled monoclonal antibodies (MoAbs) to prove disease persistence after treatment for ovarian carcinoma. Twelve patients with histologically confirmed ovarian carcinoma were studied. They received 5 mCi (1 mg) of iodine-131-B72.3 by intravenous injection before and after a complete co

Role of radioimmunoguided surgery using
✍ Enzo Lucisano; Sergio Bertoglio 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 26 KB

Uniform and accurate staging of gastric cancer is essential to predict prognosis and assess the effectiveness of treatment strategies. An appropriate amount of surgical resection of the primary tumor and lymph node dissection appears to be fundamental for such staging. In seven out of 10 patients wh

Kinetics and dosimetry of iodine-131-lab
✍ E. J. Derksen; E. B. Dieren; J. C. Roos; A. Lingen; W. Hollander; G. J. J. Teule 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 518 KB

In 11 patients with rectal cancer, a mixture of F(ab')2 fragments of anti-carcinoembryonic antigen and anti-CA 19.9 labelled with a diagnostic dose of iodine-131 (3-10 MBq) was administered submucosally around the tumour. In this study, the local kinetics in and the dose to the rectal wall, the whol

Antibody-antigen complex formation follo
✍ Hidde J. Haisma; Anne Battaile; Earl W. Stradtman; Robert C. Knapp; Vincent R. Z 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 553 KB

Monoclonal antibody (MAb) O C 125 binds to approximately 80% of epithelial ovarian cancers. Serum antigen, CAI25, can be detected in these patients. "'I-OC 125-F(ab')2 was injected into 5 ovarian carcinoma patients with preinjection serum levels of I50 to 9,000 CAI25 U/ml. Patients received the anti